A New Standard for Rapid Biological Testing

BioSense Technologies has developed a new rapid method for determining the  physiological status of cells. The company is using this technology to determine the effectiveness of therapeutic agents on eukaryotic and prokaryotic cells in real-time. Our goal is to improve the diagnosis and treatment of cancer and infectious diseases by identifying drug resistance for the administration of targeted therapies.